For more than a decade, Solpharma has successfully enabled pharma companies to access international markets…

Read More

Our Services

At Solpharma we help pharmaceutical companies develop their business in global markets. Based on our extensive network of business contacts, we craft beneficial partnerships for manufacturers, rights holders, distributors and developers of new products and technologies.
Each go-to-market process is different and calls for an individual approach. That is why we stay closely involved with every client, accompanying them all the way from negotiations to signed agreements. And we continue to assist long after the first purchase order is issued to ensure smooth supply, repeat orders and long-term business.

Market Entry

Looking to get your product into new markets? We connect you with international partners.

Market Entry

With distribution chains becoming increasingly complex, Solpharma helps manufacturers shorten time to market and generate revenue quicker.

While you focus on your core business, we identify the best international partners for you, tailor the contractual framework for distribution, out-licensing or technology transfer, coordinate registration processes and advise on pricing strategy.

Product Scouting

Looking for new products to in-license or distribute? We scout products with potentialin your market.

Product Scouting

Connected with manufacturers and medical experts around the world, we help local distribution companies and contract manufacturers find appropriate products to in-license and market in their country.

Strategic partnerships

Still in early development stage? We connect you with strategic partners to take your venture to the next level.

Strategic partnerships

Taking a new medication or device from the concept stage to the patient requires substantial resources.
We connect innovative developers and start-ups with partners who provide funding, manufacturing expertise or commercial resources to bring their product to the market.
Whether the best option is Joint Venture, technology transfer or co-development, we identify suitable partners and help our clients conclude mutually beneficial agreements.

Our Footprint

About Us


Solpharma provides business development services to pharmaceutical companies. Since our founding in 2003, we have helped dozens of medium and small manufacturers gain inroads into mass and niche markets around the globe. Connected with medical experts and stakeholders across the supply chain, we also scout new products for local distributors and find strategic partners for early stage ventures.

At Solpharma we believe that successful business development is more than matchmaking between the right players. For each product and market we develop a specific go-to-market strategy, choosing the appropriate mode of operation, whether that involves distribution and licensing agreements or sale of marketing authorization and dossiers, technology transfer or co-development. Supporting our clients on the regulatory, commercial and logistic levels, we make sure that agreements translate into revenues and long-term partnerships.

Over the past decade, we have facilitated over 100 agreements for clients developing prescription drugs, medical devices, dietary supplements and cosmetics. We reach out to over 50 countries on all continents. In 2010, Solpharma took an active role in establishing Ativa Pharma, a distributor and marketing company in Mexico which then merged with the Canadian Paladin Labs and was later acquired by Grupo Somar, an Endo affiliate.

Success Stories

Confidentiality is a fundamental value at Solpharma. Having facilitated over 100 agreements, the success stories below offer just a brief overview over our activities.


Product: API of a product for Glaucoma.
Market: Brazil
Sales revenue: 1.6 million USD
Product: Contraceptive
Markets: Israel, Turkey, Venezuela and Spain
Sales revenue: over 12 million Euros
Product: Proton pump inhibitor (PPI)
Market: Hungary
Sales revenue: over 3.4 million Euros
Product: Immunosuppressant drug
Market: Europe
Sales revenue: over 3.1 million Euros
Product: Parenteral preparations
Market: New Zealand
Sales revenue: 1.7 million Euros
Product: drug for the treatment of anemia
Market: Asia
Sales revenue: over 1 million Euros.
Product: Anticonvulsant drug in an innovative controlled-release formulation
Client: R&D company specializing in formulations of complex products
Market: Latin America

Solpharma successfully connected the R&D company with the Latin American affiliate of a multinational Pharma corporation.
The new partner provides both the manufacturing expertise and marketing infrastructure to successfully bring the drug to a commercial stage and distribute it in Latin America.
Facilitated sales of Marketing Authorizations in the fields of antibiotics, anti-inflammatory, anti-infective, CNS, gastroenterology, cardiovascular and dermatology products.
Market: Western Europe
Product: Device for cataract surgeries
Market: Europe, Latin America and South Africa
Sales revenue: over 1.5 million USD

Product: Pediatric OTC product
Market: Israel
Sales revenue: over 1.8 million USD
Project: Ativa Pharma, Mexico
Having identified a demand for specialized products in the Mexican market, Solpharma in conjunction with local partners set up Ativa Pharma, a marketing and distribution company. As its portfolio of foreign niche products penetrating the Mexican market expanded, Ativa Pharma was acquired by Endo’s Latin American affiliate in 2014.


Ehud Solel

Founder and Managing Director

Mr. Solel founded Solpharma in 2003. As its Managing Director he has built the company’s global network of business contacts and continues to expand it through strategic partnerships. An experienced executive in international trading, Mr. Solel guides clients through the implementation of agreements and helps leverage existing cooperation in additional fields. In 2010, Mr. Solel initiated and led Ativa Pharma, a marketing and distribution company in Mexico later acquired by Grupo Somar, an Endo affiliate. Prior to establishing Solpharma, Mr. Solel acted as Managing Partner at Veropharma.

Gonen Bry

Marketing and Business Development Director

Mr.Bry joined Solpharma in 2010, bringing with him 8 years of experience in international business development in EMEA. At Solpharma he leads business development activities for emerging markets in Asia, Africa, CIS and Latin America. Mr. Bry supports clients by formulating international marketing and business plans and additionally scouts new products for local distribution partners. Mr. Bry’s MA is from Sorbonne University, Paris.

Contact Us

Solpharma Ltd.
120 Pa’amonit St. Maccabim-Re’ut 7179901, Israel // tel: +972-3-9233406 // fax: +972-8-9261691 //